Monteris Names New CEO After Former Co. Head’s April Departure

Med-tech veteran takes helm, while reason for John Schellhorn's exit from the private med-tech company remain unclear.

Monteris Medical announced on Tuesday that Martin Emerson has taken over as its president and CEO after John Schellhorn, who formerly held the post, left the company for an unknown reason.
Plymouth-based Monteris made no announcement of Schellhorn’s departure, which, according to his LinkedIn account, occurred sometime in April. Twin Cities Business reached out to the private company, but a Monteris representative declined to comment on the matter.
Schellhorn became the president and CEO of Monteris in April 2012.
Emerson, his replacement, will join Monteris with more than 25 years of working in the med-tech industry.
Emerson has been the CEO of Galil Medical, a cryoablation systems maker in Arden Hills, since 2008. (Last month, Galil was purchased by BTG plc, a London-based developer of specialty healthcare products.)
Emerson also spent eight years with American Medical Systems, a urology and gynecology device company from Minnetonka. Emerson was at one point the CEO of American Medical Systems before it was sold to Endo Pharmaceuticals Holdings Inc. for $2.9 billion in 2011.
He has also held various domestic and international management positions with med-tech companies, including Boston Scientific and Baxter International.
In a statement, Emerson said, “I would like to thank the Monteris Board of Directors for the opportunity to lead a company with such exciting technology offering minimally invasive surgical alternatives with brain tumors and epilepsy.”
Monteris’ flagship product NeuroBlate, which is used as an assistive tool by neurosurgeons, was given FDA approval for use in an epilepsy study last April. The three-and-a-half year study was expected to launch sometime in the second half of 2016.